Market News
Wednesday, February 1, 2017
BRIEF-Galapagos doses first patient with novel CF corrector GLPG2222
* Reg-Galapagos doses first patient with novel CF corrector
GLPG2222
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment